Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-29

What I stated above about the Phase 1/2 stages is not correct - the Phase 1 part of the trial includes dose escalation followed by expansion (akin to Phase 1A and B) and the Phase 2 part is indeed a Phase 2 trial as explained in the Clinical Trial info... plus it is one trial but of three arms (each for one specific gastro-intestinal cancer study. Interesting how the transition to the Ph2 should be seamless with no lengthy downtime between the back-to-back trials. Maybe this is how all clinical development should be conducted(?)

https://clinicaltrials.gov/study/NCT06055439